Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

What should a cure for cancer look like?

J. Leonard Lichtenfeld, MD
Conditions
June 23, 2019
Share
Tweet
Share

Words have meaning. And when it comes to cancer, especially advanced cancer, there aren’t many words that have more meaning than the word “cure.” It is that very word and concept that is top of mind for some of us these days.

We clinicians are guilty as charged when it comes to reluctance declaring those who have had a remarkable response to treatments for advanced cancer “cured.” Experience has taught us over decades that we have misused the word and overpromised those we cared for. Our patients and loved ones have paid a price for our over-optimism. Consequently, our culture has taught us to avoid the word, lest we be shown to have been less-than-truthful when cancer returns with a vengeance.

And yet our world is changing: we are now seeing long term responses to treatments in diseases where until recently we had little hope of such success.

Recent reports of rapidly declining mortality in melanoma, normal life spans for many people treated for previously fatal diseases like chronic myelogenous leukemia, and the potential for impressive gains in outcomes for people with lung cancer are but a few examples that suggest we are indeed in a new era for cancer treatment.

So why shouldn’t we be talking about a cure for cancer?

From my perspective, there are a couple of ways to look at this concept:

  • Our research is taking us to new understandings and treatment for several cancers. Although some of these treatments may target only a small number of patients, taken together they will make a difference in the burden and suffering from cancer. We cannot and should not ignore the fact that there are more patients surviving longer because of these new treatments, some returning to full-time employment and many returning to a meaningful quality of life that would not have been the case even a few short years ago.
  • Our past should not be a barrier to our future. We should embrace the concept of cure, always keeping it top of mind, and aiming for the greatest goals we can achieve. We should accept — as I heard the former director of the National Cancer Institute and current interim commissioner of the Food and Drug Administration, Dr. Ned Sharpless, say last year in an address to the annual meeting of the American Society of Clinical Oncology that we need to address and embrace the “C” word — and appreciate that today it is within our reach for some, and soon hopefully many more.

Then there is a fundamental question: What really is a cure, and how could we make it happen?

To me, “cure” in its broadest sense is a complex equation consisting of education, awareness, access, timely diagnosis, best available treatment, and availability of the support to get through a cancer journey. At its core, “cure” is avoiding a preventable or premature death.

In that respect, we have been successful: a 27% decline in the rate of cancer deaths from 1991-2016 is proof positive. However, I firmly believe that if we optimized cancer care starting today, we could vastly reduce deaths from cancer, maybe even avoid hundreds of thousands of deaths by simply doing what we already know.

That may not be as provocative as “cures,” however the impact would be the same: avoiding cancer, finding it at a more treatable moment, getting the best available treatment. That’s what counts in reducing the cancer burden.

So instead of focusing on whether it’s appropriate to set audacious goals of curing cancer in a certain period of time, let’s focus on what we have accomplished, what we could accomplish, and what we will accomplish by confronting cancer in all its complexities, from prevention and early detection to treatment. Let’s make certain everyone knows what they could do to reduce their risk, and let’s make certain everyone has access to appropriate early detection that has been proven to work. Let’s make certain access to care is not an impediment but an opportunity to get care, and when that care is provided it is the best available care with the right treatments.

“Cure” may be a bridge too far for some, however, it should be a goal for all. And unless one makes big goals, we will continue to avoid big successes. The cure for cancer is, in fact, within our grasp. Let’s not ignore that opportunity to do better.

J. Leonard Lichtenfeld is deputy chief medical officer, American Cancer Society. He blogs at Dr. Len’s Cancer Blog.

ADVERTISEMENT

Image credit: Shutterstock.com 

Prev

Why MIPS is a useless mental exercise

June 23, 2019 Kevin 1
…
Next

6 lessons this physician learned from his father

June 23, 2019 Kevin 0
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Why MIPS is a useless mental exercise
Next Post >
6 lessons this physician learned from his father

ADVERTISEMENT

More by J. Leonard Lichtenfeld, MD

  • Removing vaccine advisers could jeopardize lives

    J. Leonard Lichtenfeld, MD
  • Why won’t unproven COVID treatments go away?

    J. Leonard Lichtenfeld, MD
  • How can we improve the quality of medications?

    J. Leonard Lichtenfeld, MD

Related Posts

  • Cancer patients who want to take unproven supplements

    Marc Braunstein, MD, PhD
  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • We have a shot at preventing cervical cancer

    Lisa N. Abaid, MD, MPH
  • Obstruction of medical justice: How health care fails patients with cancer

    Miriam A. Knoll, MD
  • Despite progress in cancer care, cost and equity challenges still must be addressed

    David M. Aboulafia, MD
  • Using the Avengers to explain how cancer treatments work

    Jennifer Lycette, MD

More in Conditions

  • Addressing menstrual health inequities in adolescents

    Callia Georgoulis
  • Healing beyond the surface: Why proper chronic wound care matters

    Alvin May, MD
  • Why specialist pain clinics and addiction treatment services require strong primary care

    Olumuyiwa Bamgbade, MD
  • What a childhood stroke taught me about the future of neurosurgery and the promise of vagus nerve stimulation

    William J. Bannon IV
  • Facing terminal cancer as a doctor and mother

    Kelly Curtin-Hallinan, DO
  • Why doctors must stop ignoring unintentional weight loss in patients with obesity

    Samantha Malley, FNP-C
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician
    • Healing beyond the surface: Why proper chronic wound care matters

      Alvin May, MD | Conditions
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician
    • Healing beyond the surface: Why proper chronic wound care matters

      Alvin May, MD | Conditions
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

What should a cure for cancer look like?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...